Skip to main content
OpenTrials

Clinical trial condition

Neovascularization, Pathologic

Explore clinical trials studying Neovascularization, Pathologic. Study availability and eligibility vary by location and protocol.

207 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Neovascularization, Pathologic trial results

Active, not recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

NCT05984927

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +11 more
Locations
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada
  • Sunnybrook Ophthalmology and Vision Services Toronto, Ontario, Canada
  • Vitreous Retina Macula Specialists of Toronto Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

NCT05407636

Conditions
AMD, CNV, Choroid Diseases, +16 more
Locations
  • Barnet Dulaney Eye Center-Phoenix /ID# 256340 Phoenix, Arizona, United States
  • Retinal Research Institute /ID# 256238 Phoenix, Arizona, United States
  • Retina Macula Institute of Arizona /ID# 271026 Scottsdale, Arizona, United States
  • California Retina Consultants - Bakersfield /ID# 256240 Bakersfield, California, United States
View all 181 locations
View Trial Details
Active, not recruiting

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

NCT04704921

Conditions
AMD, CNV, Choroid Diseases, +18 more
Locations
  • Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
  • Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States
View all 89 locations
View Trial Details
Active, not recruiting

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

NCT04645212

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations
  • Adverum Clinical Site Bakersfield, California, United States
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Lakewood, Colorado, United States
  • Adverum Clinical Site Deerfield Beach, Florida, United States
View Trial Details
Active, not recruiting

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

NCT05536973

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Adverum Clinical Site 178 Phoenix, Arizona, United States
  • Adverum Clinical Site 126 Phoenix, Arizona, United States
  • Adverum Clinical Site 159 Tucson, Arizona, United States
  • Adverum Clinical Site 100 Beverly Hills, California, United States
View all 39 locations
View Trial Details
Completed

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

NCT05666804

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Novartis Investigative Site Daegu, Dalseo Gu, South Korea
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
  • Novartis Investigative Site Daejeon, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View all 15 locations
View Trial Details

Related conditions